Last Updated: Saturday, August 8, 2015, 16:23
Drug firm Divis Laboratories today reported a 45 per cent rise in its net profit at Rs 243.18 crore for the June quarter, from Rs 167.93 crore a year ago.
Last Updated: Tuesday, July 28, 2015, 23:25
Drug firm Glenmark's generic skin care drug that was under patent litigation infinges patent of Bayer, a US court has ruled.
Last Updated: Thursday, July 23, 2015, 16:08
The company had posted a net profit after taxes and minority interest of Rs 624.74 crore for the corresponding period of the previous fiscal, Lupin said in a filing to BSE.
Last Updated: Tuesday, July 21, 2015, 22:13
Drug firm Sanofi India Tuesday reported a 11.65 percent rise in its standalone net profit at Rs 64.2 crore during second quarter ended June 30, 2015.
Last Updated: Tuesday, July 21, 2015, 11:19
Drug major Cipla on Tuesday said its board has approved a potential investment by FIL Capital Investments (Mauritius) II Ltd in its consumer healthcare business.
Last Updated: Saturday, July 18, 2015, 14:00
Drug firm Torrent Pharmaceuticals on Saturday said that it has completed acquisition of Encore Group firm Zyg Pharma Pvt Ltd.
Last Updated: Thursday, July 16, 2015, 19:05
As per the information available on the US Food and Drug Administration's (USFDA) website, Mumbai-based Wockhardt is recalling the drugs for current good manufacturing practice (CGMP) deviations.
Last Updated: Wednesday, July 15, 2015, 14:44
Drug firm Pfizer is planning to close its Navi Mumbai plant from September 16, 2015.
Last Updated: Wednesday, June 24, 2015, 12:31
With this approval, the group has received 100 approvals and has so far filed 260 ANDAs (abbreviated new drug applications).
Last Updated: Wednesday, June 10, 2015, 17:55
The approval of shareholders is sought through a postal ballot. The e-voting will commence on June 10 and end on July 9, the company said in a filing to BSE.
Last Updated: Tuesday, May 26, 2015, 14:10
The Mumbai-based firm along with many other companies had received communication from EMA for suspension of Trimetazidine MR 35 mg and Cefpodoxime 200 mg tablets in January 2015.
Last Updated: Saturday, May 23, 2015, 14:58
The company had posted a net profit of Rs 196.43 crore in the corresponding period of the previous fiscal, Divis Laboratories said in a filing to BSE.
more videos >>
